GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
- PMID: 30639358
- PMCID: PMC6408327
- DOI: 10.1016/j.cmet.2018.12.016
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
Abstract
GDF15 is an established biomarker of cellular stress. The fact that it signals via a specific hindbrain receptor, GFRAL, and that mice lacking GDF15 manifest diet-induced obesity suggest that GDF15 may play a physiological role in energy balance. We performed experiments in humans, mice, and cells to determine if and how nutritional perturbations modify GDF15 expression. Circulating GDF15 levels manifest very modest changes in response to moderate caloric surpluses or deficits in mice or humans, differentiating it from classical intestinally derived satiety hormones and leptin. However, GDF15 levels do increase following sustained high-fat feeding or dietary amino acid imbalance in mice. We demonstrate that GDF15 expression is regulated by the integrated stress response and is induced in selected tissues in mice in these settings. Finally, we show that pharmacological GDF15 administration to mice can trigger conditioned taste aversion, suggesting that GDF15 may induce an aversive response to nutritional stress.
Keywords: GDF15; GFRAL; conditioned taste aversion; integrated stress response; overnutrion.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
![None](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6408327/bin/fx1.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6408327/bin/gr1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6408327/bin/gr2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6408327/bin/gr3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6408327/bin/gr4.gif)
Comment in
-
GDF15 signals nutritional stress.Nat Rev Endocrinol. 2019 Mar;15(3):130. doi: 10.1038/s41574-019-0167-9. Nat Rev Endocrinol. 2019. PMID: 30692652 No abstract available.
Similar articles
-
Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice.Mol Metab. 2023 Aug;74:101760. doi: 10.1016/j.molmet.2023.101760. Epub 2023 Jun 24. Mol Metab. 2023. PMID: 37356805 Free PMC article.
-
Stress-induced FGF21 and GDF15 in obesity and obesity resistance.Trends Endocrinol Metab. 2021 Nov;32(11):904-915. doi: 10.1016/j.tem.2021.08.008. Epub 2021 Sep 13. Trends Endocrinol Metab. 2021. PMID: 34526227 Review.
-
GDF15: A Hormone Conveying Somatic Distress to the Brain.Endocr Rev. 2020 Aug 1;41(4):bnaa007. doi: 10.1210/endrev/bnaa007. Endocr Rev. 2020. PMID: 32310257 Free PMC article. Review.
-
GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS.Int J Obes (Lond). 2019 Dec;43(12):2370-2380. doi: 10.1038/s41366-019-0365-5. Epub 2019 May 31. Int J Obes (Lond). 2019. PMID: 31152154
-
GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.Mol Metab. 2019 Mar;21:13-21. doi: 10.1016/j.molmet.2019.01.003. Epub 2019 Jan 14. Mol Metab. 2019. PMID: 30685336 Free PMC article.
Cited by
-
Different roles of circulating and intramuscular GDF15 as markers of skeletal muscle health.Front Endocrinol (Lausanne). 2024 May 14;15:1404047. doi: 10.3389/fendo.2024.1404047. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38808117 Free PMC article.
-
Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.Cardiovasc Diabetol. 2024 May 18;23(1):174. doi: 10.1186/s12933-024-02264-5. Cardiovasc Diabetol. 2024. PMID: 38762719 Free PMC article.
-
GDF15 knockout does not substantially impact perinatal body weight or neonatal outcomes in mice.bioRxiv [Preprint]. 2024 May 3:2024.04.30.591359. doi: 10.1101/2024.04.30.591359. bioRxiv. 2024. PMID: 38746399 Free PMC article. Preprint.
-
Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy.J Exp Med. 2024 Jul 1;221(7):e20231395. doi: 10.1084/jem.20231395. Epub 2024 May 2. J Exp Med. 2024. PMID: 38695876
-
GDF-15 Suppresses Puromycin Aminonucleoside-Induced Podocyte Injury by Reducing Endoplasmic Reticulum Stress and Glomerular Inflammation.Cells. 2024 Apr 5;13(7):637. doi: 10.3390/cells13070637. Cells. 2024. PMID: 38607075 Free PMC article.
References
-
- Appierto V., Tiberio P., Villani M.G., Cavadini E., Formelli F. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation. Carcinogenesis. 2009;30:824–831. - PubMed
-
- Badman M.K., Pissios P., Kennedy A.R., Koukos G., Flier J.S., Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5:426–437. - PubMed
-
- Böttner M., Suter-Crazzolara C., Schober A., Unsicker K. Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res. 1999;297:103–110. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 200848/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- DH_/Department of Health/United Kingdom
- U54 GM104940/GM/NIGMS NIH HHS/United States
- 106263/Z/14/Z/WT_/Wellcome Trust/United Kingdom
- 095515/Z/11/Z/WT_/Wellcome Trust/United Kingdom
- MC_UU_00014/5/MRC_/Medical Research Council/United Kingdom
- MC_UU_12012/1/MRC_/Medical Research Council/United Kingdom
- Wellcome Trust/United Kingdom
- G0600717/MRC_/Medical Research Council/United Kingdom
- MC_UU_00014/2/MRC_/Medical Research Council/United Kingdom
- MC_UU_12012/3/MRC_/Medical Research Council/United Kingdom
- MC_UU_00014/3/MRC_/Medical Research Council/United Kingdom
- 107064/Wellcome Trust/United Kingdom
- MC_UU_12012/2/MRC_/Medical Research Council/United Kingdom
- 106262/Z/14/Z/WT_/Wellcome Trust/United Kingdom
- 098497/Z/12/Z/WT_/Wellcome Trust/United Kingdom
- G0802051/MRC_/Medical Research Council/United Kingdom
- G9824984/MRC_/Medical Research Council/United Kingdom
- 100574/Z/12/Z/WT_/Wellcome Trust/United Kingdom
- G0900554/MRC_/Medical Research Council/United Kingdom
- G0400192/MRC_/Medical Research Council/United Kingdom
- WT 107064/WT_/Wellcome Trust/United Kingdom
- MC_UU_00014/1/MRC_/Medical Research Council/United Kingdom
- 100140/Wellcome Trust/United Kingdom
- MC_UU_12012/5/MRC_/Medical Research Council/United Kingdom
- RG/12/13/29853/BHF_/British Heart Foundation/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous